keyword
MENU ▼
Read by QxMD icon Read
search

Pygeum africanum

keyword
https://www.readbyqxmd.com/read/27180172/phytotherapy-for-benign-prostatic-hyperplasia
#1
REVIEW
Aryeh Keehn, Jacob Taylor, Franklin C Lowe
INTRODUCTION: The use of complementary and alternative medications for symptomatic benign prostatic hyperplasia is a lucrative business in the USA with revenues reaching close to US$6.4 billion in sales for the 2014 fiscal year. Yet, despite its popularity, the evidence supporting the continued use of phytotherapy for symptomatic benign prostatic hyperplasia (BPH) is questionable and a topic worth investigation given its wide spread use. METHODS: A comprehensive literature search utilizing Medline and PubMed was conducted to identify literature pertaining to phytotherapy for the management of BPH...
July 2016: Current Urology Reports
https://www.readbyqxmd.com/read/26497340/complementary-and-alternative-medications-for-benign-prostatic-hyperplasia
#2
REVIEW
Aryeh Keehn, Franklin C Lowe
INTRODUCTION: The use of complementary and alternative medications has become a multi-million dollar business in the United States and comprises more than half of all filled prescriptions for benign prostatic hyperplasia (BPH) in Europe. For the practicing urologist, understanding the phytotherapeutic agents available, their proposed mechanism of action, the research supporting their use, and their safety profiles has become increasingly important as more patients inquire into their use...
October 2015: Canadian Journal of Urology
https://www.readbyqxmd.com/read/25703069/what-do-we-know-about-phytotherapy-of-benign-prostatic-hyperplasia
#3
REVIEW
Olta Allkanjari, Annabella Vitalone
Benign prostatic hyperplasia (BPH) is one of the most common urological diseases in aging men. Because of its long latency, BPH is a good target for prevention. The aim of the study has been to review the various options of treatment, currently available, in the field of phytotherapy. Watchful waiting, pharmacological therapy, and surgery are also helpful, depending on the severity of the disease. Although drug therapy (alpha1-blockers, 5alpha-reductase inhibitors) and surgery (prostatectomy, transurethral resection, etc...
April 1, 2015: Life Sciences
https://www.readbyqxmd.com/read/25165780/phytotherapy-of-benign-prostatic-hyperplasia-a-minireview
#4
REVIEW
Ester Pagano, Massimiliano Laudato, Michele Griffo, Raffaele Capasso
Benign prostate hyperplasia (BPH) is a common condition affecting older men, with an incidence that is age-dependent. Histological BPH, which typically develops after the age of 40 years, ranges in prevalence from >50% at 60 years to as high as 90% by 85 years of age. Typical symptoms include increased frequency of urination, nocturia, urgency, hesitancy, and weak urine stream. Conventional medicines used for the treatment of BPH include alpha blockers and 5-alpha reductase inhibitors. This articles review the mode of action, the efficacy, and the safety, including herb-drug interactions of the most common botanicals (Serenoa repens, Pygeum africanum, Urtica dioica, and Cucurbita pepo) and nutraceuticals (isoflavones, lycopene, selenium, and β-Sitosterol) in controlling the lower urinary tract symptoms associated to BPH...
July 2014: Phytotherapy Research: PTR
https://www.readbyqxmd.com/read/23642948/a-phase-ii-randomised-double-blind-placebo-controlled-clinical-trial-investigating-the-efficacy-and-safety-of-prostateeze-max-a-herbal-medicine-preparation-for-the-management-of-symptoms-of-benign-prostatic-hypertrophy
#5
RANDOMIZED CONTROLLED TRIAL
Samantha Coulson, Amanda Rao, Shoshannah L Beck, Elizabeth Steels, Helen Gramotnev, Luis Vitetta
OBJECTIVE: The aim of the clinical trial was to evaluate the efficacy and safety of ProstateEZE Max, an orally dosed herbal preparation containing Cucurbita pepo, Epilobium parviflorum, lycopene, Pygeum africanum and Serenoa repens in the management of symptoms of medically diagnosed benign prostate hypertrophy (BPH). DESIGN: This was a short-term phase II randomized double-blind placebo controlled clinical trial. SETTING: The trial was conducted on 57 otherwise healthy males aged 40-80 years that presented with medically diagnosed BPH...
June 2013: Complementary Therapies in Medicine
https://www.readbyqxmd.com/read/23194959/inhibition-of-5-%C3%AE-reductase-and-aromatase-by-phl-00801-prostatonin%C3%A2-a-combination-of-py102-pygeum-africanum-and-ur102-urtica-dioica-extracts
#6
R W Hartmann, M Mark, F Soldati
This study was undertaken to evaluate a possible effect of the extracts PY102 of Pygeum africanum (Hook), and UR 102 of Urtica dioica L. as well as their combination PHL-00801 (Prostatonin®) on the enzymes 5 α-reductase (5 α-RE) and aromatase (AR): Inhibition of 5 α-RE: Pygeum africanum extract PY 102, and Urtica dioica extract UR 102, inhibited the 5 α-RE activity in a concentration dependent manner. Whereas UR102 extract was only able to influence the enzyme activity at high concentrations (≥ 12mg/ml) and its ED(50) being calculated as 14...
September 1996: Phytomedicine: International Journal of Phytotherapy and Phytopharmacology
https://www.readbyqxmd.com/read/23165347/cytotoxicity-of-herbal-extracts-used-for-treatment-of-prostatic-disease-on-head-and-neck-carcinoma-cell-lines-and-non-malignant-primary-mucosal-cells
#7
Marianne Schmidt, Christine Polednik, Jeanette Roller, Rudolf Hagen
Previously, a growth inhibiting effect of PC-Spes on head and neck carcinoma cell lines had been demonstrated. In order to determine the toxic impact of particular herbs in the mixture, we exposed the head and neck cancer cell lines FADU, HLaC79 and its Paclitaxel-resistant subline HLaC79-Clone1 as well as primary mucosal keratinocytes to increasing concentrations of the herbal mixture Prostaprotect, which has a similar formulation as PC-Spes, as well as its single herbal components Dendranthema morifolium, Ganoderma lucidium, Glycyrrhiza glabra, Isatis indigotica, Panax pseudo-ginseng, Rabdosia rubescens, Scutellaria baicalensis and Pygeum africanum...
February 2013: Oncology Reports
https://www.readbyqxmd.com/read/23058996/-phytotherapy-in-urology-current-scientific-evidence-of-its-application-in-benign-prostatic-hyperplasia-and-prostate-adenocarcinoma
#8
REVIEW
E Morán, A Budía, E Broseta, F Boronat
OBJECTIVE: To evaluate the usefulness of phytotherapy in the treatment of the benign prostatic hyperplasia (BPH) and prostatic adenocarcinoma (ADCP). ACQUISITION OF EVIDENCE: Systematic review of the evidence published until January 2011 using the following scientific terms: phytotherapy, benign prostate hyperplasia, prostatic adenocarcinoma, prostate cancer and the scientific names of compounds following the rules of the International Code of Botanical Nomenclature...
February 2013: Actas Urologicas Españolas
https://www.readbyqxmd.com/read/22512478/a-review-of-animal-and-human-studies-for-management-of-benign-prostatic-hyperplasia-with-natural-products-perspective-of-new-pharmacological-agents
#9
REVIEW
Hanieh Azimi, Ali-Asghar Khakshur, Iman Aghdasi, Mehrnaz Fallah-Tafti, Mohammad Abdollahi
OBJECTIVE: In this paper, we reviewed plants being effective in treatment of BPH for the purpose of finding new sources of pharmaceutical agents. METHODS: All pertinent literature databases were searched. The search keywords were plant, herb, herbal therapy, phytotherapy, benign prostatic hyperplasia, BPH, and prostate. All of the human, animal and in vitro studies were evaluated. RESULTS: According to the studies, some of the substantial effective constituents of the plants in treatment of BPH are oenothein B, icaritin, xanthohumol, diarylheptanoid, 2,6,4'-trihydroxy-4-methoxybenzophenone, emodin, fatty acids, atraric acid, n-butylbenzene-sulfonamide, curbicin, theaflavin-3,30-digallate, penta-O-galloyl-b-D-glucose, lycopene, sinalbin, β-sitosterol, secoisolariciresinol diglucoside, genistein, apigenin, baicalein, and daidzein...
June 2012: Inflammation & Allergy Drug Targets
https://www.readbyqxmd.com/read/22198631/biological-effect-of-human-serum-collected-before-and-after-oral-intake-of-pygeum-africanum-on-various-benign-prostate-cell-cultures
#10
Stéphane Larré, Philippe Camparo, Eva Comperat, Delphine Boulbés, Mohammed Haddoum, Sylvain Baulande, Pascal Soularue, Pierre Costa, Olivier Cussenot
Pygeum africanum (Tadenan) is a popular phytotherapeutic agent used in the treatment of symptomatic benign prostatic hyperplasia. The active compounds of the drug have not been identified, and determining the plasma concentration of the drug is, therefore, not possible. Because there are conflicting results on the efficacy of this drug, we aimed to investigate its effect on prostate cell growth in vitro using human serum collected before and after Pygeum africanum intake. We used primary and organotypic cultures of human prostatic stromal myofibroblast cell line WPMY and prostatic epithelial cell line PNT2...
May 2012: Asian Journal of Andrology
https://www.readbyqxmd.com/read/21871136/benign-prostatic-hyperplasia-and-male-lower-urinary-tract-symptoms-luts
#11
REVIEW
Tom McNicholas, Roger Kirby
INTRODUCTION: Lower urinary tract symptoms related to benign prostatic hyperplasia (BPH) and bladder outlet obstruction may affect up to 30% of men in their early 70s. Symptoms can improve without treatment, but the usual course is a slow progression of symptoms, with acute urinary retention occurring in 1% to 2% of men with BPH per year. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of medical, herbal, and surgical treatments? We searched: Medline, Embase, The Cochrane Library, and other important databases up to July 2009 (Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review)...
2011: Clinical Evidence
https://www.readbyqxmd.com/read/20965230/the-natural-compounds-atraric-acid-and-n-butylbenzene-sulfonamide-as-antagonists-of-the-human-androgen-receptor-and-inhibitors-of-prostate-cancer-cell-growth
#12
REVIEW
Daniela Roell, Aria Baniahmad
Extracts from the plant Pygeum africanum are widely used in the therapy of benign prostate hyperplasia (BPH) and in combinational therapy for prostate cancer, the second leading cause of cancer death and the mostly diagnosed form of cancer in men. The androgen receptor (AR) plays a crucial role in the development of the prostate as well as in prostate diseases. Even though the extracts from P. africanum are considered as beneficial for prostate diseases in clinical trials, and some active compounds for treatment of BPH could be identified, compounds responsible for AR inhibition and the molecular mechanism for inhibition of prostatitis need to be identified...
January 30, 2011: Molecular and Cellular Endocrinology
https://www.readbyqxmd.com/read/20944533/serenoa-repens-in-benign-prostatic-hypertrophy-analysis-of-2-italian-studies
#13
MULTICENTER STUDY
F Mantovani
AIM: Benign prostatic hypertrophy (BPH), which is characterized by a progressive swelling of the prostate causing symptoms of the lower urinary tract, is the second pathology as frequency among the diagnoses placed in men every year in Italy. The extract of Serenoa repens is an alternate therapeutic option to traditional drug therapies with a good profile of efficacy and safety for the management of the symptoms of BPH. The aim of this paper was to analyze systematically the results of two Italian studies carried out on patients with BPH treated with extract of serenoa repens (SABA...
December 2010: Minerva Urologica e Nefrologica, the Italian Journal of Urology and Nephrology
https://www.readbyqxmd.com/read/20503393/antiproliferative-and-apoptotic-effects-of-the-herbal-agent-pygeum-africanum-on-cultured-prostate-stromal-cells-from-patients-with-benign-prostatic-hyperplasia-bph
#14
Maria T Quiles, Maria A Arbós, Antònia Fraga, Inés M de Torres, Jaume Reventós, Juan Morote
BACKGROUND: Previous reports show that the herbal agent Pygeum africanum (PA) used to treat benign prostatic hyperplasia (BPH) inhibits proliferation of prostate stromal cells from BPH tissues. To determine underlying mechanisms, we compared proliferative and apoptotic responses to PA between BPH and non-BPH prostate stromal cells with a focus on the specific reaction displayed by stromal cell subsets. An interaction of PA with growth factors and hormones was also investigated. METHODS: Primary prostate stromal cells from BPH/LUTS patients undergoing open prostatectomy (n = 3) and patients without benign prostatic hyperplasia (BPH) undergoing cystectomy (n = 3) were treated with PA...
July 1, 2010: Prostate
https://www.readbyqxmd.com/read/20490673/nerve-growth-factor-and-substance-p-expression-in-a-rat-model-of-diabetic-bladder
#15
COMPARATIVE STUDY
Yongzhi Li, Benkang Shi, Dan Wang, Ping Wang, Vincent Laudon, Jianping Zhang, Yili Liu
OBJECTIVE: To evaluate the gene and protein expression of nerve growth factor (NGF) and substance P (SP) in the bladder 8 weeks after diabetes induction and investigate the pathogenesis of diabetic cystopathy. METHODS: Thirty Wistar rats were divided into three groups: control (n = 10), streptozotocin-induced diabetic group (n = 10) and Pygeum africanum (P. africanum) group (n = 10; diabetic rats were given P. africanum (100 mg/kg/day)). Eight weeks later, the bladders were dissected...
March 2011: International Urology and Nephrology
https://www.readbyqxmd.com/read/20007408/redesigning-a-large-scale-clinical-trial-in-response-to-negative-external-trial-results-the-camus-study-of-phytotherapy-for-benign-prostatic-hyperplasia
#16
Jeannette Lee, Gerald Andriole, Andrew Avins, E David Crawford, Harris Foster, Steven Kaplan, Karl Kreder, John Kusek, Andrew McCullough, Kevin McVary, Sreelatha Meleth, Michael Naslund, J Curtis Nickel, Leroy Nyberg, Claus Roehrborn, O Dale Williams, Michael Barry
BACKGROUND: Benign prostatic hyperplasia (BPH), a common condition among older men, confers its morbidity through potentially bothersome lower urinary tract symptoms. Treatments for BPH include drugs such as alpha-adrenergic receptor blockers and 5-alpha reductase inhibitors, minimally invasive therapies that use heat to damage or destroy prostate tissue, and surgery including transurethral resection of the prostate. Complementary and alternative medicines are gaining popularity in the US...
December 2009: Clinical Trials: Journal of the Society for Clinical Trials
https://www.readbyqxmd.com/read/19771394/nbbs-isolated-from-pygeum-africanum-bark-exhibits-androgen-antagonistic-activity-inhibits-ar-nuclear-translocation-and-prostate-cancer-cell-growth
#17
Maria Papaioannou, Sonja Schleich, Daniela Roell, Undine Schubert, Tamzin Tanner, Frank Claessens, Rudolf Matusch, Aria Baniahmad
Extracts from Pygeum africanum are used in the treatment of prostatitis, benign prostatic hyperplasia (BPH) and prostate cancer (PCa). The ligand-activated human androgen receptor (AR) is known to control the growth of the prostate gland. Inhibition of human AR is therefore a major goal in treatment of patients. Here, we characterize the compound N-butylbenzene-sulfonamide (NBBS) isolated from P. africanum as a specific AR antagonist. This antihormonal activity inhibits AR- and progesterone receptor- (PR) mediated transactivation, but not the related human glucocorticoid receptor (GR) or the estrogen receptors (ERα or ERβ)...
December 2010: Investigational New Drugs
https://www.readbyqxmd.com/read/19609708/pygeum-africanum-effect-on-oxidative-stress-in-early-diabetes-induced-bladder
#18
Dan Wang, Yongzhi Li, Guihua Hou, Ping Wang, Jianping Zhang, Vincent Laudon, Benkang Shi
OBJECTIVE: To evaluate the effect of Pygeum africanum on oxidative stress and functional changes of the bladder after diabetes induction. MATERIALS AND METHODS: Thirty-two adult Wistar male rats were treated daily for 8 weeks and grouped as follows: Control group (n = 6), Streptozotocin-induced diabetic group (n = 10), diabetes plus P. africanum group (n = 10), and control plus P. africanum group (n = 6). After diabetes induction for 4 weeks, the diabetes plus P...
June 2010: International Urology and Nephrology
https://www.readbyqxmd.com/read/18627423/the-natural-compound-atraric-acid-is-an-antagonist-of-the-human-androgen-receptor-inhibiting-cellular-invasiveness-and-prostate-cancer-cell-growth
#19
Maria Papaioannou, Sonja Schleich, Ina Prade, Stephanie Degen, Daniela Roell, Undine Schubert, Tamzin Tanner, Frank Claessens, Rudolf Matusch, Aria Baniahmad
Extracts from Pygeum africanum are used in the treatment of prostatitis, benign prostatic hyperplasia and prostate cancer (Pca), major health problems of men in Western countries. The ligand-activated human androgen receptor (AR) supports the growth of the prostate gland. Inhibition of human AR by androgen ablation therapy and by applying synthetic anti-androgens is therefore the primary goal in treatment of patients. Here, we show that atraric acid (AA) isolated from bark material of Pygeum africanum has anti-androgenic activity, inhibiting the transactivation mediated by the ligand-activated human AR...
August 2009: Journal of Cellular and Molecular Medicine
https://www.readbyqxmd.com/read/18423748/phytotherapy-for-lower-urinary-tract-symptoms-secondary-to-benign-prostatic-hyperplasia
#20
REVIEW
Raj C Dedhia, Kevin T McVary
PURPOSE: We examined the available data from clinical trials for certain botanicals used for lower urinary tract symptoms secondary to benign prostatic hyperplasia, including Serenoa repens (saw palmetto), Pygeum africanum (African plum), Secale cereale (rye pollen) and Hypoxis rooperi (South African star grass). MATERIALS AND METHODS: MEDLINE and The Cochrane Library searches were done in June 2007 using the terms benign prostatic hyperplasia, lower urinary tract symptoms, phytotherapy, saw palmetto, Serenoa, Permixon, Pygeum africanum, Tadenan, Cernilton, Cernitin and Hypoxis...
June 2008: Journal of Urology
keyword
keyword
105132
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"